FDA approves first prescription app for depression

FDA approves first prescription app for depression

The US Food and Drug Administration (FDA) has approved the first prescription application for major depressive disorder (MDD). The app, Rejoyn, was developed by Otsuka Pharmaceutical and Click Therapeutics. It …

Read more

The truth about GLP-1 compounds that doctors need to know

The truth about GLP-1 compounds that doctors need to know

As a cardiologist specializing in obesity medicine, I often encounter patients who would greatly benefit from the new generation of weight loss drugs that work as glucagon-like peptide 1 (GLP-1) …

Read more